Cargando…

Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma

BACKGROUND: Cyclin D1 gene regulates cell cycle and plays an important role in the tumorigenesis of human cancers. The association between cyclin D1, clinicopathologic parameters and prognosis in oral cavity squamous cell carcinoma (OSCC) is inconclusive. METHODS: A total of 264 male OSCCs were exam...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shiang-Fu, Cheng, Sou-De, Chuang, Wen-Yu, Chen, I-How, Liao, Chun-Ta, Wang, Hung-Ming, Hsieh, Ling-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312822/
https://www.ncbi.nlm.nih.gov/pubmed/22336657
http://dx.doi.org/10.1186/1477-7819-10-40
_version_ 1782227889123491840
author Huang, Shiang-Fu
Cheng, Sou-De
Chuang, Wen-Yu
Chen, I-How
Liao, Chun-Ta
Wang, Hung-Ming
Hsieh, Ling-Ling
author_facet Huang, Shiang-Fu
Cheng, Sou-De
Chuang, Wen-Yu
Chen, I-How
Liao, Chun-Ta
Wang, Hung-Ming
Hsieh, Ling-Ling
author_sort Huang, Shiang-Fu
collection PubMed
description BACKGROUND: Cyclin D1 gene regulates cell cycle and plays an important role in the tumorigenesis of human cancers. The association between cyclin D1, clinicopathologic parameters and prognosis in oral cavity squamous cell carcinoma (OSCC) is inconclusive. METHODS: A total of 264 male OSCCs were examined for cyclin D1 protein expression using immunohistochemistry (IHC). The expression levels of cyclin D1 were defined as overexpression when more than 10% of tumor cells displayed nuclear staining with moderate to strong intensity. RESULTS: Overexpression of cyclin D1 was found in 97 (36.7%) OSCCs. Cyclin D1 protein overexpression was significantly associated with lymph node metastasis (P = 0.002), tumor cell differentiation (P = 0.031) and tumor stage (P = 0.051), but not associated with age onset, cigarette smoking, alcohol drinking, or areca quid chewing. Overexpression of cyclin D1 was also significantly associated with poor clinical outcomes in terms of disease-free survival (DFS, P = 0.002) and overall survival (OS, P < 0.001). The effects of cyclin D1 protein overexpression on DFS (hazard ratio (HR) = 1.540; 95% confidence interval (CI), 1.068 - 2.222) and OS (HR = 1.702; 95% CI, 1.168 - 2.480) were still existed after adjusting for clinicopathological paremeters (such as age, primary tumor status, tumor cell differentiation, and lymph node metastasis) using logistic multivariate analysis. CONCLUSION: Cyclin D1 protein worked as an independent prognostic factor and can be as a biomarker for the aggressiveness of OSCC.
format Online
Article
Text
id pubmed-3312822
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33128222012-03-27 Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma Huang, Shiang-Fu Cheng, Sou-De Chuang, Wen-Yu Chen, I-How Liao, Chun-Ta Wang, Hung-Ming Hsieh, Ling-Ling World J Surg Oncol Research BACKGROUND: Cyclin D1 gene regulates cell cycle and plays an important role in the tumorigenesis of human cancers. The association between cyclin D1, clinicopathologic parameters and prognosis in oral cavity squamous cell carcinoma (OSCC) is inconclusive. METHODS: A total of 264 male OSCCs were examined for cyclin D1 protein expression using immunohistochemistry (IHC). The expression levels of cyclin D1 were defined as overexpression when more than 10% of tumor cells displayed nuclear staining with moderate to strong intensity. RESULTS: Overexpression of cyclin D1 was found in 97 (36.7%) OSCCs. Cyclin D1 protein overexpression was significantly associated with lymph node metastasis (P = 0.002), tumor cell differentiation (P = 0.031) and tumor stage (P = 0.051), but not associated with age onset, cigarette smoking, alcohol drinking, or areca quid chewing. Overexpression of cyclin D1 was also significantly associated with poor clinical outcomes in terms of disease-free survival (DFS, P = 0.002) and overall survival (OS, P < 0.001). The effects of cyclin D1 protein overexpression on DFS (hazard ratio (HR) = 1.540; 95% confidence interval (CI), 1.068 - 2.222) and OS (HR = 1.702; 95% CI, 1.168 - 2.480) were still existed after adjusting for clinicopathological paremeters (such as age, primary tumor status, tumor cell differentiation, and lymph node metastasis) using logistic multivariate analysis. CONCLUSION: Cyclin D1 protein worked as an independent prognostic factor and can be as a biomarker for the aggressiveness of OSCC. BioMed Central 2012-02-16 /pmc/articles/PMC3312822/ /pubmed/22336657 http://dx.doi.org/10.1186/1477-7819-10-40 Text en Copyright ©2012 Huang et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Huang, Shiang-Fu
Cheng, Sou-De
Chuang, Wen-Yu
Chen, I-How
Liao, Chun-Ta
Wang, Hung-Ming
Hsieh, Ling-Ling
Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma
title Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma
title_full Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma
title_fullStr Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma
title_full_unstemmed Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma
title_short Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma
title_sort cyclin d1 overexpression and poor clinical outcomes in taiwanese oral cavity squamous cell carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312822/
https://www.ncbi.nlm.nih.gov/pubmed/22336657
http://dx.doi.org/10.1186/1477-7819-10-40
work_keys_str_mv AT huangshiangfu cyclind1overexpressionandpoorclinicaloutcomesintaiwaneseoralcavitysquamouscellcarcinoma
AT chengsoude cyclind1overexpressionandpoorclinicaloutcomesintaiwaneseoralcavitysquamouscellcarcinoma
AT chuangwenyu cyclind1overexpressionandpoorclinicaloutcomesintaiwaneseoralcavitysquamouscellcarcinoma
AT chenihow cyclind1overexpressionandpoorclinicaloutcomesintaiwaneseoralcavitysquamouscellcarcinoma
AT liaochunta cyclind1overexpressionandpoorclinicaloutcomesintaiwaneseoralcavitysquamouscellcarcinoma
AT wanghungming cyclind1overexpressionandpoorclinicaloutcomesintaiwaneseoralcavitysquamouscellcarcinoma
AT hsiehlingling cyclind1overexpressionandpoorclinicaloutcomesintaiwaneseoralcavitysquamouscellcarcinoma